Study data on quality of life for breast cancer patients and survivors, supported by napo pharmaceuticals (a jaguar health family company), published on san antonio breast cancer symposium (sabcs) website

San francisco, ca / accesswire / december 6, 2023 / napo pharmaceuticals (napo), a jaguar health, inc. (nasdaq:jagx) family company, today announced that the abstract for "more than a diagnosis: a quality of life survey for individuals with a diagnosis or history of cancer," an online, anonymous napo-supported survey initiative of advocates for collaborative education (ace) to shed light on the diverse and profound challenges faced by individuals living with a diagnosis or a history of cancer, is now available on the website for the december 2023 san antonio breast cancer symposium (sabcs). the complete set of abstracts submitted to sabcs 2023 can be viewed by clicking here.
JAGX Ratings Summary
JAGX Quant Ranking